Podcasts about neurology journal

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 2901: Mind-body interventions like yoga, meditation, and tai chi do more than just reduce stress, they may actually alter gene expression and lower the risk of inflammation-related diseases. Carolyn Joyce explores research showing how these practices counteract the harmful effects of chronic stress on a molecular level, potentially slowing cellular aging and improving mental health. Incorporating these techniques into daily life could not only enhance well-being but also contribute to long-term physical health. Read along with the original article(s) here: https://www.psychalive.org/new-benefits-mind-body-interventions/ Quotes to ponder: "Mind–body therapies focus on the relationships among the brain, mind, body, and behavior, and their effect on health and disease." "This response may precipitate a health risk when stress is severe or it occurs over a long period of time without adequate coping mechanisms." "Mind-body interventions can improve a person's level of mental health when compared to those who do not practice these techniques." Episode references: Neurology Journal: https://n.neurology.org/ Alberta Health Services – University of Calgary Study: https://www.albertahealthservices.ca Frontiers in Immunology: https://www.frontiersin.org/articles/10.3389/fimmu.2017.00670/full Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 2901: Mind-body interventions like yoga, meditation, and tai chi do more than just reduce stress, they may actually alter gene expression and lower the risk of inflammation-related diseases. Carolyn Joyce explores research showing how these practices counteract the harmful effects of chronic stress on a molecular level, potentially slowing cellular aging and improving mental health. Incorporating these techniques into daily life could not only enhance well-being but also contribute to long-term physical health. Read along with the original article(s) here: https://www.psychalive.org/new-benefits-mind-body-interventions/ Quotes to ponder: "Mind–body therapies focus on the relationships among the brain, mind, body, and behavior, and their effect on health and disease." "This response may precipitate a health risk when stress is severe or it occurs over a long period of time without adequate coping mechanisms." "Mind-body interventions can improve a person's level of mental health when compared to those who do not practice these techniques." Episode references: Neurology Journal: https://n.neurology.org/ Alberta Health Services – University of Calgary Study: https://www.albertahealthservices.ca Frontiers in Immunology: https://www.frontiersin.org/articles/10.3389/fimmu.2017.00670/full Learn more about your ad choices. Visit megaphone.fm/adchoices

Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting multiple sclerosis (RRMS) in the peer-reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology. Vitt noted that the EMPhASIS trial demonstrated a notable reduction in gadolinium-enhancing lesions by 78% and 74% in two high-dose groups compared with the placebo. These results also correlate with improvements in serum neurofilament light chain levels, consistent with recent interim phase 2 clinical data from the ongoing CALLIPER trial in progressive MS, indicating ongoing progress in the field. Vitt highlighted the study's contribution to understanding the neuroprotective and anti-inflammatory effects of the treatment under investigation. The drug's potential impact on the treatment landscape of MS, particularly its role in addressing disease progression independent of relapse activity, was emphasized. Immunic is also conducting the CALLIPER trial in progressive MS, with key results expected by April 2025. Additionally, the phase 3 ENSURE trials are actively enrolling, with projected readouts in 2026. Dr Vitt expressed optimism about the drug's unique profile, combining safety and effectiveness in potentially altering the management of all forms of MS. #ImmunicInc, #DrDanielVitt, #EMPHASISTrial, #MultipleSclerosis, #MSResearch, #Neurology, #ClinicalTrials, #Phase2, #Phase3, #DrugDevelopment, #MedicalInnovation, #Neuroprotection, #AntiInflammatory, #Healthcare, #MedicalJournal, #AmericanAcademyOfNeurology, #Gadolinium, #SerumNeurofilament, #ProgressiveMS, #NeurodegenerativeDiseases #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Dr. Zafer Keser reviews the article, "Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory" published in the March 21, 2022, Neurology Journal. Show references: https://n.neurology.org/content/98/12/486

Is amyloid the right target for new Alzheimer's disease therapies? Will any of these therapies, if they win approval, advance the treatment of Alzheimer's disease? Our faculty explores these and other questions. Visit www.morningcommutepodcast.com/ad2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

Dr. Douglas Katz discusses the Neurology Journal article, "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome". Show references: https://n.neurology.org/content/early/2021/03/15/WNL.0000000000011850  

Dr. Adam de Havenon discusses the Neurology Journal article, "Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D". Show references: https://n.neurology.org/content/96/16/e2132

Are there viable blood tests on the horizon to make diagnosis, and particularly early diagnosis, of Alzheimer's disease possible? Our faculty takes a look at this excited field that may also enable development of better therapeutics for the disease. Visit www.morningcommutepodcast.com/ad1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

Visit journalclubpodcasts.com/als to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this activity, two experts discuss several papers showing how the virus may affect ALS patients as well as what they are seeing in their clinics.

Dr. Chloe E. Hill discusses the Neurology Journal article, "Increasing Out-of-Pocket Costs for Neurologic Care for Privately-Insured Patients". Show references: https://n.neurology.org/content/early/2020/12/23/WNL.0000000000011278

Visit journalclubpodcasts.com/parkinsonsdisease to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this activity, two experts discuss a paper published in the Journal of Clinical Medicine that looked at the impact of Covid-19 on patients with Parkinson's disease—physically, emotionally, and how they are keeping up with their treatments

In the first segment, Dr. Jeff Burns speaks with Dr. Michael Weiner about his New York Times article on blood tests for Alzheimer’s disease. Read the NYT article here: https://nyti.ms/3cKheMW. Next, Dr. David Lapides talks with Dr. Martin Monti about his Neurology Journal paper on subcortical involvement in traumatic brain injury.  Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by completing the online Podcast quiz.

Dr. John Chen discusses his paper, "Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder". Show References: https://n.neurology.org/content/early/2020/06/16/WNL.0000000000009758 https://www.neurology.org/podcast  

Dr. Roseanne Dobkin discusses her paper, "Telephone-based Cognitive Behavioral Therapy for Depression in Parkinson Disease". Show References: Paper: https://n.neurology.org/content/94/16/e1764 Podcast: https://neurology.libsyn.com/website  

Dr. Fabio Nascimento discusses the article, "Cephalic Tetanus - Not Every Facial Weakness is Bell Palsy". Article: https://n.neurology.org/content/93/21/e1995 Video: https://www.youtube.com/watch?v=V1pr644hneQ    

Dr. Kimbra Kenney and Dr. Jessica M. Gill discuss their article entitled, "Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury?" To read the article, click here: https://n.neurology.org/content/94/23/e2412.abstract

Dr. Ana Catarina Fonseca discusses her article in the Neurology Journal entitled, "Undetermined Stroke Genesis and Hidden Cardiomyopathies Determined by Cardiac Magnetic Resonance" You can read the article here:  https://n.neurology.org/content/94/1/e107  

Dr. David Watson discusses the management of migraines for patients.  You can hear the full-length interview here:  https://neurology.libsyn.com/website

Dr. Jason Sico discusses the purpose of quality measurement sets. 

Dr. Jeff Ratliff discusses an article from the Neurology Journal entitled, "Progression and Prognosis in Multiple System Atrophy Presenting with REM Behavior Disorder" You can read the article here: https://n.neurology.org/content/94/17/e1828

Dr. Fabio Nascimento discusses an article from the Resident and Fellow Section of the Neurology Journal entitled, "Medically intractable epilepsy and ictal asystole treated with cardiac pacing". You can read the article here: https://n.neurology.org/content/92/21/e2510

Dr. Yves Dauvilliers discusses his paper entitled, "Daridorexant, a New Dual Orexin Receptor Antagonist, in Elderly Subjects with Insomnia Disorder". You can read the article here: https://n.neurology.org/content/94/21/e2222 You can hear the full interview here: https://neurology.libsyn.com/website  

Dr. Steven R. Messe shares a summary of his paper, "Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention" from the Neurology Journal. You can listen to the full podcast here: https://neurology.libsyn.com/website You can find the article here:  https://n.neurology.org/content/early/2020/04/28/WNL.0000000000009443

Maureen A. Mealy, PhD, RN discusses the findings from her study on Scrambler Therapy for pain in neuromyelitis optica.  You can read the study here: https://n.neurology.org/content/94/18/e1900

Dr. Adam Brickman discusses his paper, "White Matter Hyperintensities Mediate the Association of Nocturnal Blood Pressure with Cognition". You can read the paper here: https://n.neurology.org/content/early/2020/04/15/WNL.0000000000009316 

Dr. Karen G. Hirsch discusses her paper entitled, "Neurology Journal: Prognostic Value of Diffusion-Weighted MRI for Post-Cardiac Arrest Coma".  

Dr. Richard B. Lipton discusses his paper entitled, "Efficacy and Safety of Eptinezumab in Patients with Chronic Migraine"

Dr. Christina Sjöstrand discusses her paper entitled, "Sickness absence and disability pension days in patients with cluster headache and matched references". You can read the article here: https://n.neurology.org/content/early/2020/02/05/WNL.0000000000009016

Daniel Hartung discusses his recent paper in the Neurology Journal entitled, "Effect of Generic Glatiramer Acetate on Spending and use of Drugs for Multiple Sclerosis".   You can read the paper here: https://n.neurology.org/content/early/2020/01/15/WNL.0000000000008936

Dr.  Callaghan discusses his paper entitled, "Association of Out-of-pocket Costs on Adherence to Common Neurologic Medications" You can read the paper here: https://n.neurology.org/content/early/2020/02/18/WNL.0000000000009039

Dr. Fredrik Piehl discusses his article, "Blood Neurofilament-Light Levels Segregate Treatment Effects in Patients with Multiple Sclerosis"

Dr. John Noseworthy discusses his paper, "The Future of Care — Preserving the Patient-Physician Relationship"

Dr. Ryan Schubert & Dr. Michael Wilson discuss their article, "Pan-Viral Serology Implicates Enteroviruses in Acute Flaccid Myelitis".  

Dr. Emma Foster discusses her article, "Antiepileptic drugs are not independently associated with cognitive dysfunction".

Dr. David Lapides talks with Dr. Riley Bove about her Neurology: Neuroimmunology & Neuroinflammation paper, "Minimal Breastmilk Transfer of Rituximab, a Monoclonal Antibody used in Neurological Conditions."

Dr. Jason Crowell speaks with Wall Street Journal reporter, Denise Roland, about her article, "Obscure Model Puts a Price on Good Health—and Drives Down Drug Costs".

Dr. Kevin Sheth discusses his article, "Racial/Ethnic Disparities in the Risk of Intracerebral Hemorrhage Recurrence". Read the article here: https://n.neurology.org/content/94/3/e314

Dr. Stacey Clardy interviews Dr. Jaideep Kapur and Dr. Robert Silbergleit about their article,"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus". You can read it here: https://www.nejm.org/doi/full/10.1056/NEJMoa1905795  

Dr. David Lapides talks with Dr. Francesc Graus about his paper, "Clinical Features of Seronegative, but CSF Antibody-Positive, Anti-NMDA Receptor Encephalitis" You can read the article here:  https://nn.neurology.org/content/7/2/e659

Dr. Josep Dalmau discusses his article, "Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis" with Dr. David Lapides.

Dr. Ken Tylers shares the neuroinfectious diseases that should be on our radar in 2020.

Dr. Teshamae Monteith interviews Dr. Francesca Puledda about her recent article on visual snow syndrome.

Dr. Jason Crowell speaks with Ed Silverman with STAT News about the article

Dr. Jeffrey Burns interviews Dr. Amy Sanders on the AAN's new update to the dementia management quality measurement set.

Dr. Crowell interviews Dr. Timothy Yu about his article "Patient-customized oligonucleotide therapy for a rare genetic disease." Read the NEJM article: https://www.nejm.org/doi/full/10.1056/NEJMoa1813279. 

Dr. Daniel Hartung discusses the take-home message from his paper, "Qualitative study on the price of drugs for multiple sclerosis".

Coming Soon. From the editors of the Neurology Journal, Neurology Minute is a daily 1-2 minute brief podcast delivering a quick, practical rundown of what you need to know in neurology. Neurology Minute is hosted by Dr. Stacey Clardy, with contributions by leading neurologists and neuroscientists.

1) The Effects of Orthostatic Hypotension on Cognition in Parkinson's Disease 2) What's Trending: Carotid surgery trials3) Topic of the Month: Neuromuscular topicsThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the first segment, Dr. Matthew Barrett interviews Dr. Justin Centi about his paper on the effects of orthostatic hypotension on cognition in Parkinson disease. Dr. Andy Southerland is interviewing Dr. Seemant Chaturvedi for our “What's Trending” feature of the week about urgency for carotid surgery trials. In the next part of the podcast, Dr. Ted Burns interviews Dr. Michelle Mauermann about neuromuscular topics. Disclosures can be found at www.neurology.org.DISCLOSURES: Dr. Barrett has received research support from Axovant Sciences, Inc., the Virginia Center of Alzheimer's and Related Diseases, and the Department of Defense.Dr. Centi has been an employee of Commonwealth Psychology Associates LLC and Harvard Medical School/Partners Consortium in Neuropsychology; and has received research support from NIH-NINDS.Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review. Dr. Chaturvedi has been a consultant for Merck; has served on the executive committee of ACT I study and CREST 2 study; serves on the editorial boards of Neurology, the Journal of Stroke & Cerebrovascular Disease, Stroke, and NEJM Journal Watch Neurology; has received research support from Boehringer-Ingelheim, NINDS, and the FDA; and has received compensation for expert witness testimony.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc. Dr. Mauermann serves on the editorial board of Mayo Clinic Proceedings; receives publishing royalties for book Autonomic Neurology; and receives research support from Ionis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals.All other participants have no disclosures.

1) AAN guideline summary: Treatment of restless legs syndrome in adults 2) What's Trending: Interview with Dr. Steven Messé on why acute ischemic stroke patients are not receiving IV tPA3) Topic of the month: Neurology Today story about cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out forThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Fullard interviews Dr. John Winkelman about the AAN guideline summary on the treatment of restless legs syndrome in adults. Dr. Andy Southerland is interviewing Dr. Steven Messé for our “What's Trending” feature of the week about his paper on why are acute ischemic stroke patients not receiving IV tPA. In the next part of the podcast Dr. Ted Burns interviews Drs. Kevin Messacar and Ken Tyler about a Neurology Today story on the topic on cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out for.DISCLOSURES: Dr. Winkelman serves as Associate Editor for Sleep; serves as an editorial board member of Sleep Medicine and CNS Drugs; received honoraria from serving on the scientific advisory board of Merck Serono, Flex Pharma, UCB, Impax Pharmaceuticals, Pfizer Inc, Lacrima, Luitpold Pharmaceuticals, GlaxoSmithKline, Boehringer Ingelheim, Xenoport, Zeo Inc., Sunovion, Insys, Takeda Pharmaceutical Company Limited, Jazz and Neurogen; receives royalties from the publication of the books: Foundations of Psychiatric Sleep Medicine and Nocturnal Leg Cramps; holds stock options in Flex Pharma; provided expert witness work for ArentFox and CantorColburn; received funding for travel from Novartis and Otsuka; currently performs neurophysiology studies as part of his practice;receives research support from Xenoport, GlaxoSmithKline, UCB, Sepracor, Pfizer Inc, Impax Pharmaceuticals, Purdue, Neurometrix and the NIH.Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review.Dr. Messé received publishing royalties from UpToDate; received compensation from GlaxoSmithKline for consulting on protocol development for a trial of a neuroprotectant in high risk surgery; received research support from GlaxoSmithKline, Bayer Schering Pharma, WL Gore and the NIH.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Tyler serves as an Associate Editor for Journal of Neurovirology and Neurology Today; serves as an editorial board member for Annals of Neurology, Apoptosis, JAMA Neurology, Experimental Neurology, Journal of Infectious Disease, Microbial Pathogenesis, Virology, Neurology ALL Current; serves on the scientific advisory board for PML Consortium; is a consultant for Hoffman La Roche; receives royalties from the publication of the books: Handbook of Clinical Neurology and Harrison's Principles & Practices of Internal Medicine; receives research support from the NIH. All other participants report no disclosures.

1) Systematic review and statistical analysis of the integrity of 33 randomized controlled trials2) What's Trending: Interview with Dr. Neil Garrett about his Nature Neuroscience article on dishonesty.3) Topic of the month: Neurology Today story about Zika virus and Guillain Barre syndrome detected in ColumbiaThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Mark Bolland about his paper on the systematic review and statistical analysis of the integrity of 33 randomized controlled trials. Dr. Ted Burns is also interviewing Dr. Neil Garrett for our “What's Trending” feature of the week about his Nature Neuroscience paper on dishonesty. In the next part of the podcast Dr. Ted Burns interviews Dr. Carlos Pardo about a Neurology Today story on the topic of Zika virus and Guillain Barre syndrome detected in Columbia.DISCLOSURES: Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Bolland receives research support from the Health Research Council of New Zealand.Dr. Pardo receives research support from Bart McLean Fund for Neuroimmunology Research-Project Restore and the NIH.All other participants report no disclosures.